Trial Profile
Psoriasis-topoproteome under ustekinumab treatment (PIROUETTE-Study) - as an interventional observation study (phase IV) within approved label and indication and with minimal invasive taking of skin biopsies - as an investigator originated proposal (IOP) / investigator initiated study/trial (IIS/T) according to AMG and GCP regulations.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2013
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms PIROUETTE
- 30 Mar 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 25 Jun 2011 New trial record